US Executive Compensation Proxy SEC Filings — September 08, 2026

08-09-2026

Lantheus Holdings, Inc. has filed a definitive proxy statement (DEFM14A) for a special meeting of stockholders to vote on a proposed merger agreement under which the company will be acquired by Parent and become a wholly owned subsidiary, with its common stock delisted from Nasdaq. The merger is expected to close in the first half of 2027, subject to stockholder approval and regulatory clearances. Termination fees are asymmetric: Lantheus would pay Parent $228 million under certain circumstances, while Parent would pay Lantheus $385 million or a regulatory termination fee of $100 million under other conditions.

• · Lantheus is a radiopharmaceutical-focused company headquartered in Bedford, Massachusetts with offices in New Jersey, Canada, Germany, Switzerland, Sweden and the United Kingdom.
• · The company's commercial products are used by cardiologists, internists, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists.
• · PYLARIFY TruVu, a new formulation of F-18 prostate-specific membrane antigen PET imaging agent, was approved by the FDA on March 6, 2026.
• · LNTH-2501, an investigational kit for Gallium-68 edotreotide injection, received a Complete Response Letter from the FDA on June 26, 2026, with unresolved facility inspection related conditions.
• · PNT2003 received FDA tentative approval earlier in 2026, but faces patent litigation on appeal before the Court of Appeals for the Federal Circuit.
• · The company has experienced recent turnover in its leadership and senior management team.
• · Stockholder litigation in connection with the proposed acquisition may result in significant costs of defense, indemnification and liability.

08-09-2026

Cayson Acquisition Corp (CAPNR) is seeking shareholder approval at an Extraordinary General Meeting to extend the deadline to complete an initial business combination beyond September 23, 2026, and to amend the Trust Agreement to allow for revised payment terms. Insiders, who beneficially own 1,730,000 ordinary shares (32.7% of outstanding shares), intend to vote in favor of the proposals. If the extension is not approved and no business combination is completed by the current deadline, the company will dissolve and liquidate, with public shareholders receiving a pro rata distribution from the trust account.

• · The deadline to complete a business combination is currently September 23, 2026.
• · If the Extension Proposal is not approved and no business combination is completed by the deadline, the company will cease operations, redeem public shares, and liquidate.
• · Insiders may purchase public shares in privately negotiated transactions or open market prior to the meeting, but have no current commitments to do so.
• · The Adjournment Proposal will not be presented if both the Extension and Trust Amendment Proposals are approved.
• · Approval of the Extension Proposal requires a special resolution (at least two-thirds of votes cast).
• · Approval of the Trust Amendment and Adjournment Proposals requires a simple majority of votes cast.

08-09-2026

Hussman Investment Trust is holding a special shareholder meeting on October 15, 2026, to elect six trustees: three current trustees (John P. Hussman, David C. Anderson, William H. Vanover) and three new candidates (Peter W. Atwater, Chris S. Jones, Grant D. Williams). The board recommends voting 'FOR' all nominees to expand experience and ensure orderly succession. There are no financial results or monetary performance figures to report.

• · Record date for shareholder eligibility: September 1, 2026
• · Special meeting date: October 15, 2026, at 10:00 a.m. Eastern time
• · Location: Ultimus Fund Solutions, LLC, 225 Pictoria Drive, Suite 450, Cincinnati, Ohio 45246
• · Current board has 3 trustees (1 interested, 2 independent); proposal expands to 6 trustees (1 interested, 5 independent)
• · Proxy materials available at www.OkapiVote.com/Hussman
• · Shareholders have one vote for each dollar of net asset value held
• · Each Fund bears its proportionate share of meeting expenses based on assets

08-09-2026

Seagate Technology Holdings plc filed its definitive proxy statement (DEF 14A) for the 2026 Annual General Meeting to be held virtually on October 24, 2026. The meeting includes proposals for director elections, an advisory say-on-pay vote, ratification of Ernst & Young as independent auditors, and Irish law share authority items. The filing also discloses executive compensation details for Fiscal Year 2026, including a CEO pay ratio and pay-versus-performance data.

• · The 2026 AGM will be held virtually on October 24, 2026 at 5:00 p.m. Singapore Standard Time.
• · Record date for shareholders is August 26, 2026.
• · Proposals 5 and 6 are special resolutions requiring at least 75% of votes cast; Proposals 1-4 are ordinary resolutions requiring majority approval.
• · The Board recommends voting FOR all director nominees and all proposals.
• · Proxy materials are being furnished over the Internet, with mailing on or about September 8, 2026.
• · The proxy statement includes the Irish statutory financial statements for FY2026, which will be presented but not subject to shareholder approval.
• · Shareholders can vote via Internet, telephone, or mail by October 23, 2026.

08-09-2026

iPower Inc. is seeking stockholder approval for two proposals at a Special Meeting: (1) authorization to issue up to $10,000,000 (or 10,000,000 shares) of common stock in a private placement or registered offering to unidentified investors, with a discount of up to 15% below the Nasdaq Minimum Price, and (2) approval of a reverse stock split of up to 1-for-250 to maintain Nasdaq listing compliance. The company's insider ownership is minimal, with all officers and directors holding only 0.7% of shares, and no 5% beneficial owners are listed. The stock offering could cause substantial dilution, and the reverse split does not guarantee compliance with Nasdaq's bid price requirement.

• · Chenlong Tan's holdings consist of 15,843 shares directly held, 16,667 shares held by a trust, 3,240 vested options, and 10,142 vested RSUs with deferred settlement, plus 14,260 unvested options.
• · Yue Guo holds 459 shares and 1,952 unvested RSUs.
• · Hanxi Li holds 826 shares and 1,953 RSUs that will not vest within 60 days.
• · Bennet Tchaikovsky holds 1,245 shares and 3,904 RSUs that will not vest within 60 days.
• · Yi Yang holds no shares.
• · The reverse stock split may be effected on one or more occasions within twelve months from the Special Meeting.
• · The board will announce the chosen reverse split ratio at least five business days prior to effectiveness.
• · The stock offering may not include variable-price resets, make-whole share issuance, or anti-dilution adjustments except customary adjustments.
• · The company expects to use proceeds for working capital, AI and supply-chain initiatives, equipment or infrastructure expenditures, repayment of indebtedness, and general corporate purposes.

08-09-2026

Richtech Robotics Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders to be held on September 29, 2026. The meeting will include the re-election of directors Saul Factor and John Shigley, and the ratification of CBIZ CPAs P.C. as independent auditor for fiscal year ending September 30, 2026. The Board unanimously recommends votes 'FOR' both proposals. As of the record date, there are 39,934,846 shares of Class A common stock (10 votes each) and 185,167,097 shares of Class B common stock (1 vote each) outstanding.

• · Annual Meeting to be held on September 29, 2026 at 10:00 a.m. Pacific Time at 2975 Lincoln Rd, Las Vegas, NV 89115.
• · Record date for voting is August 25, 2026.
• · Proxy materials first mailed on or about September 8, 2026.
• · Each share of Class A common stock entitles holder to 10 votes; each share of Class B common stock entitles holder to 1 vote.
• · Directors to be re-elected for a three-year term expiring at the 2029 Annual Meeting.
• · Ratification of CBIZ CPAs P.C. as independent auditor for fiscal year ending September 30, 2026.

08-09-2026

Baillie Gifford ETF Trust and Baillie Gifford Funds are soliciting shareholder approval to reclassify the Baillie Gifford Emerging Markets Equities Fund and the Baillie Gifford Emerging Markets ETF from 'diversified' to 'non-diversified' under the Investment Company Act of 1940. The Board and investment manager unanimously recommend the change, arguing it will provide greater flexibility to manage concentrated positions in high-conviction holdings. Shareholders will vote at separate virtual special meetings on November 4, 2026.

• · Record date for voting is September 4, 2026.
• · Proxy materials are being mailed on or about September 16, 2026.
• · Votes must be received by Broadridge by 9:00 a.m. Eastern Time on November 4, 2026.
• · The EM Mutual Fund typically holds 60–100 growth companies; the EM ETF may invest up to 70% of net assets in depositary receipts.
• · The reclassification would change each Fund's fundamental investment policy regarding diversification, but the investment objective and other policies remain unchanged.